Medicine Description finorate 250mg
Finorate 250mg Capsule is a medication that primarily functions by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha). This activation leads to increased fatty acid oxidation and decreased triglyceride synthesis in the liver, ultimately reducing plasma triglyceride levels. Additionally, it enhances the clearance of triglyceride-rich lipoproteins from the bloodstream. By promoting the breakdown of lipids, Fenofibrate assists in lowering the levels of low-density lipoprotein (LDL) cholesterol while modestly increasing high-density lipoprotein (HDL) cholesterol, contributing to an improved lipid profile.
Indications and Uses of Finorate 250mg Capsule
- Management of hyperlipidemia, specifically elevated triglycerides in patients with primary hyperlipidemia.
- Adjunctive therapy in patients with mixed dyslipidemia that includes high levels of LDL cholesterol and triglycerides.
- Reduction of cardiovascular risk in patients with dyslipidemia, particularly those with additional risk factors.
Side Effects of Finorate 250mg Capsule
- Gastrointestinal disturbances, such as abdominal pain, diarrhea, and nausea.
- Muscle-related issues, including myopathy and rhabdomyolysis, particularly when used with statins.
- Fatigue and headache.
- Elevated liver enzymes, which may require monitoring during treatment.
Storage and Handling
Store Finorate 250mg Capsules in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Patient Advice and Precautions
Consult with a healthcare provider before starting Finorate to ensure it aligns with your health conditions. Inform your doctor of any other medications you are taking to prevent potential interactions. Regular monitoring of lipid levels and liver function tests is recommended during treatment. Adopting lifestyle changes such as a heart-healthy diet and regular physical activity can enhance the effectiveness of this medication.